Publikationen, an denen er mitarbeitet MYRIAM SAÍNZ RAMOS (12)

2023

  1. Assessment of Different Niosome Formulations for Optogenetic Applications: Morphological and Electrophysiological Effects

    Pharmaceutics, Vol. 15, Núm. 7

  2. Erratum: Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases (ACS Appl. Mater. Interfaces (2022) 14:11 (13665−13677) DOI: 10.1021/acsami.2c02182)

    ACS Applied Materials and Interfaces

  3. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

    International Journal of Pharmaceutics, Vol. 639

2022

  1. Multicomponent Synthesis of Unsaturated γ-Lactam Derivatives. Applications as Antiproliferative Agents through the Bioisosterism Approach: Carbonyl vs. Phosphoryl Group

    Pharmaceuticals, Vol. 15, Núm. 5

  2. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 11, pp. 13665-13677

2021

  1. A multicomponent protocol for the synthesis of highly functionalized γ-lactam derivatives and their applications as antiproliferative agents

    Pharmaceuticals, Vol. 14, Núm. 8

  2. Applying 3D constructs for gene therapy

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 93-95

  3. Correlation between biophysical properties of niosomes elaborated with chloroquine and different tensioactives and their transfection efficiency

    Pharmaceutics, Vol. 13, Núm. 11

  4. How far are non‐viral vectors to come of age and reach clinical translation in gene therapy?

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  5. Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 169, pp. 103-112

2020

  1. Niosome-based approach for in situ gene delivery to retina and brain cortex as immune-privileged tissues

    Pharmaceutics, Vol. 12, Núm. 3

  2. Non-viral mediated gene therapy in human cystic fibrosis airway epithelial cells recovers chloride channel functionality

    International Journal of Pharmaceutics, Vol. 588